Skip to main content
. 2015 Jan 28;5:8068. doi: 10.1038/srep08068

Figure 3. Analysis of cell death modality and timing after exposure to ASNase.

Figure 3

B-ALL (RS(4, 11), Nalm-6) and malignant NK (MEC04, KHYG1) cell lines were treated with increasing doses of pegylated-r-crisantaspase (from 5 × 10−5 to 5 U/ml). Non-treated cells served as controls. The percentage of early apoptotic (Annexin V+/PI−) and late apoptotic (Annexin V+/PI+) was determined by flow cytometry after Annexin V/PI staining.